188 related articles for article (PubMed ID: 37740841)
1. Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment.
Zhou J; Huang W; Zhang Z; Luo L; Ren F; Huang D; Tang L
Clin Rheumatol; 2023 Dec; 42(12):3251-3255. PubMed ID: 37740841
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal Antiinflammatory Drugs as Potential Disease-Modifying Medications in Axial Spondyloarthritis.
Wang R; Bathon JM; Ward MM
Arthritis Rheumatol; 2020 Apr; 72(4):518-528. PubMed ID: 31705611
[TBL] [Abstract][Full Text] [Related]
4. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
Curtis JR; Palmer JL; Reed GW; Greenberg J; Pappas DA; Harrold LR; Kremer JM
Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1114-1124. PubMed ID: 32374918
[TBL] [Abstract][Full Text] [Related]
5. Safety of treatment options for spondyloarthritis: a narrative review.
D'Angelo S; Carriero A; Gilio M; Ursini F; Leccese P; Palazzi C
Expert Opin Drug Saf; 2018 May; 17(5):475-486. PubMed ID: 29505325
[TBL] [Abstract][Full Text] [Related]
6. Combination biologics or targeted synthetic disease-modifying anti-rheumatic drugs in the treatment of spondyloarthritis: a systematic literature review.
Abedalweli R; Nguyen M; Deodhar A
Expert Rev Clin Immunol; 2024 Jul; 20(7):735-743. PubMed ID: 38512065
[TBL] [Abstract][Full Text] [Related]
7. 2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis.
Wendling D; Lukas C; Prati C; Claudepierre P; Gossec L; Goupille P; Hudry C; Miceli-Richard C; Molto A; Pham T; Saraux A; Dougados M
Joint Bone Spine; 2018 May; 85(3):275-284. PubMed ID: 29407043
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
Varkas G; Jans L; Cypers H; Van Praet L; Carron P; Elewaut D; Van den Bosch F
Arthritis Rheumatol; 2016 Mar; 68(3):672-8. PubMed ID: 26473982
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.
Hazlewood GS; Barnabe C; Tomlinson G; Marshall D; Devoe DJ; Bombardier C
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010227. PubMed ID: 27571502
[TBL] [Abstract][Full Text] [Related]
10. Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study.
Ganapati A; Gowri M; Antonisamy B; Danda D
Clin Rheumatol; 2021 May; 40(5):1871-1879. PubMed ID: 33058032
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
12. Peripheral spondyloarthritis: Concept, diagnosis and treatment.
Molto A; Sieper J
Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):357-368. PubMed ID: 31171308
[TBL] [Abstract][Full Text] [Related]
13. Uveitis in seronegative arthritis.
Wendling D
Curr Rheumatol Rep; 2012 Oct; 14(5):402-8. PubMed ID: 22736066
[TBL] [Abstract][Full Text] [Related]
14. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT;
Ann Rheum Dis; 2015 Jun; 74(6):970-8. PubMed ID: 25710471
[TBL] [Abstract][Full Text] [Related]
15. New evidence on the management of spondyloarthritis.
Sieper J; Poddubnyy D
Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
[TBL] [Abstract][Full Text] [Related]
16. The use of biologics for uveitis associated with spondyloarthritis.
Arepalli S; Rosenbaum JT
Curr Opin Rheumatol; 2019 Jul; 31(4):349-354. PubMed ID: 31107288
[TBL] [Abstract][Full Text] [Related]
17. Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis.
Wu JJ; Pelletier C; Ung B; Tian M; Khilfeh I; Curtis JR
Adv Ther; 2020 May; 37(5):2098-2115. PubMed ID: 32141018
[TBL] [Abstract][Full Text] [Related]
18. Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Wang S; He Q; Shuai Z
Clin Rheumatol; 2018 Feb; 37(2):439-450. PubMed ID: 29290076
[TBL] [Abstract][Full Text] [Related]
19. The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
Webers C; Kiltz U; Braun J; van der Heijde D; Boonen A
Rheumatology (Oxford); 2023 Jun; 62(6):2139-2146. PubMed ID: 36205588
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis.
Hazlewood GS; Barnabe C; Tomlinson G; Marshall D; Devoe D; Bombardier C
BMJ; 2016 Apr; 353():i1777. PubMed ID: 27102806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
